vs
爱尔康(ALC)与凯雷集团(CG)财务数据对比。点击上方公司名可切换其他公司
爱尔康的季度营收约是凯雷集团的1.4倍($2.6B vs $1.9B),凯雷集团净利率更高(18.8% vs 6.8%,领先12.1%),凯雷集团同比增速更快(84.1% vs 4.0%)
爱尔康是瑞美合资的制药及医疗器械企业,专注于眼健康护理产品领域。公司注册地为瑞士弗里堡州,全球总部设于日内瓦,核心运营基地位于美国得克萨斯州沃思堡,当地员工规模约4500人。
凯雷集团是美国知名跨国企业,核心业务涵盖私募股权投资、另类资产管理及金融服务领域。截至2023年,公司管理资产总规模达4260亿美元,是全球另类资管行业的重要参与者。
ALC vs CG — 直观对比
营收规模更大
ALC
是对方的1.4倍
$1.9B
营收增速更快
CG
高出80.1%
4.0%
净利率更高
CG
高出12.1%
6.8%
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $2.6B | $1.9B |
| 净利润 | $176.0M | $358.1M |
| 毛利率 | 53.5% | — |
| 营业利润率 | 9.5% | 24.3% |
| 净利率 | 6.8% | 18.8% |
| 营收同比 | 4.0% | 84.1% |
| 净利润同比 | -21.1% | 69.8% |
| 每股收益(稀释后) | $0.35 | $0.96 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ALC
CG
| Q4 25 | — | $1.9B | ||
| Q3 25 | — | $332.7M | ||
| Q2 25 | $2.6B | $1.6B | ||
| Q1 25 | — | $973.1M | ||
| Q4 24 | — | $1.0B | ||
| Q3 24 | — | $2.6B | ||
| Q2 24 | $2.5B | $1.1B | ||
| Q1 24 | — | $688.4M |
净利润
ALC
CG
| Q4 25 | — | $358.1M | ||
| Q3 25 | — | $900.0K | ||
| Q2 25 | $176.0M | $319.7M | ||
| Q1 25 | — | $130.0M | ||
| Q4 24 | — | $210.9M | ||
| Q3 24 | — | $595.7M | ||
| Q2 24 | $223.0M | $148.2M | ||
| Q1 24 | — | $65.6M |
毛利率
ALC
CG
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 53.5% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 55.0% | — | ||
| Q1 24 | — | — |
营业利润率
ALC
CG
| Q4 25 | — | 24.3% | ||
| Q3 25 | — | 25.8% | ||
| Q2 25 | 9.5% | 28.0% | ||
| Q1 25 | — | 17.6% | ||
| Q4 24 | — | 25.7% | ||
| Q3 24 | — | 29.9% | ||
| Q2 24 | 12.7% | 20.5% | ||
| Q1 24 | — | 17.5% |
净利率
ALC
CG
| Q4 25 | — | 18.8% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | 6.8% | 20.3% | ||
| Q1 25 | — | 13.4% | ||
| Q4 24 | — | 20.4% | ||
| Q3 24 | — | 22.6% | ||
| Q2 24 | 8.9% | 13.9% | ||
| Q1 24 | — | 9.5% |
每股收益(稀释后)
ALC
CG
| Q4 25 | — | $0.96 | ||
| Q3 25 | — | $0.00 | ||
| Q2 25 | $0.35 | $0.87 | ||
| Q1 25 | — | $0.35 | ||
| Q4 24 | — | $0.56 | ||
| Q3 24 | — | $1.63 | ||
| Q2 24 | $0.45 | $0.40 | ||
| Q1 24 | — | $0.18 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $2.0B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $22.1B | $7.1B |
| 总资产 | $31.4B | $29.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ALC
CG
| Q4 25 | — | $2.0B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | $1.4B | $1.3B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | $1.4B | $914.8M | ||
| Q1 24 | — | $1.3B |
股东权益
ALC
CG
| Q4 25 | — | $7.1B | ||
| Q3 25 | — | $6.8B | ||
| Q2 25 | $22.1B | $6.7B | ||
| Q1 25 | — | $6.4B | ||
| Q4 24 | — | $6.3B | ||
| Q3 24 | — | $6.3B | ||
| Q2 24 | $20.9B | $5.7B | ||
| Q1 24 | — | $5.7B |
总资产
ALC
CG
| Q4 25 | — | $29.1B | ||
| Q3 25 | — | $27.1B | ||
| Q2 25 | $31.4B | $25.1B | ||
| Q1 25 | — | $24.1B | ||
| Q4 24 | — | $23.1B | ||
| Q3 24 | — | $22.7B | ||
| Q2 24 | $29.7B | $22.3B | ||
| Q1 24 | — | $20.8B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $-1.2B |
| 自由现金流经营现金流 - 资本支出 | — | $-1.2B |
| 自由现金流率自由现金流/营收 | — | -65.1% |
| 资本支出强度资本支出/营收 | — | 2.2% |
| 现金转化率经营现金流/净利润 | — | -3.34× |
| 过去12个月自由现金流最近4个季度 | — | $-3.4B |
8季度趋势,按日历期对齐
经营现金流
ALC
CG
| Q4 25 | — | $-1.2B | ||
| Q3 25 | — | $-1.6B | ||
| Q2 25 | — | $-168.8M | ||
| Q1 25 | — | $-352.1M | ||
| Q4 24 | — | $-352.8M | ||
| Q3 24 | — | $791.9M | ||
| Q2 24 | — | $-1.3B | ||
| Q1 24 | — | $71.1M |
自由现金流
ALC
CG
| Q4 25 | — | $-1.2B | ||
| Q3 25 | — | $-1.6B | ||
| Q2 25 | — | $-186.3M | ||
| Q1 25 | — | $-368.8M | ||
| Q4 24 | — | $-379.5M | ||
| Q3 24 | — | $772.8M | ||
| Q2 24 | — | $-1.3B | ||
| Q1 24 | — | $56.9M |
自由现金流率
ALC
CG
| Q4 25 | — | -65.1% | ||
| Q3 25 | — | -475.7% | ||
| Q2 25 | — | -11.8% | ||
| Q1 25 | — | -37.9% | ||
| Q4 24 | — | -36.8% | ||
| Q3 24 | — | 29.3% | ||
| Q2 24 | — | -120.4% | ||
| Q1 24 | — | 8.3% |
资本支出强度
ALC
CG
| Q4 25 | — | 2.2% | ||
| Q3 25 | — | 7.0% | ||
| Q2 25 | — | 1.1% | ||
| Q1 25 | — | 1.7% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.7% | ||
| Q1 24 | — | 2.1% |
现金转化率
ALC
CG
| Q4 25 | — | -3.34× | ||
| Q3 25 | — | -1732.78× | ||
| Q2 25 | — | -0.53× | ||
| Q1 25 | — | -2.71× | ||
| Q4 24 | — | -1.67× | ||
| Q3 24 | — | 1.33× | ||
| Q2 24 | — | -8.57× | ||
| Q1 24 | — | 1.08× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALC
暂无分部数据
CG
| Fund Management Fee | $606.8M | 32% |
| Other | $528.7M | 28% |
| Global Private Equity Segment | $307.3M | 16% |
| Global Credit Segment | $238.0M | 13% |
| Carlyle Alp Invest Segment | $124.6M | 7% |
| Incentive Fee | $55.4M | 3% |
| Fee Related Performance Revenues | $29.2M | 2% |
| Investment Advice | $11.1M | 1% |